K852478

Substantially Equivalent

ENZYGNOST + ANTI-CMV IGG TEST

Applicant: Behring Diagnostics, Inc.
Product code: LFZ
Advisory panel: Microbiology
Date received: 1985-06-11
Decision date: 1985-09-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: La Jolla, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.